Ngokohlaziyo lwakamuva lwe-meta, i-positron emission tomography/computed tomography (PET/CT) kanye ne-multi-parameter magnetic resonance imaging (mpMRI) inikeza amazinga afanayo okutholwa ekuxilongeni umdlavuza wendlala yesinye (PCa) ukuphindeka.
Abacwaningi bathola ukuthi i-prostate ethize i-membrane antigen (PSMA) PET/CT inenani eliphelele lokutholwa lamaphesenti angama-69 wokuphindaphinda komdlavuza wendlala yesinye, uma kuqhathaniswa namaphesenti angama-70 we-mpMRI.
“Ekubuyeni [kwe-biochemical relapse], zombili lezi zindlela ziyasebenza. Imiphumela yethu ibonisa ukuthi awukho umehluko obalulekile ku-DR (izinga lokubona) iyonke phakathi kwezindlela ezimbili zokucabanga, futhi i-mpMRI ibiza kakhulu ngenkathi igcina i-DR efanayo, "ubhale umbhali ohlangene wocwaningo u-L. Xu, osebenzisana neSikole se-School of Umuthi. Hunan University of Traditional Chinese Medicine, Hunan, China kanye nozakwabo.
Ngokuphindaphindiwe kwe-PCa yendawo, abalobi bocwaningo baqaphele ukuthi i-DR On mpMRI yayiyi-10% ephakeme (62% vs. 52%). Abacwaningi baphinde bathola ukuthi i-PSMA PET/CT ibonise ukuthuthukiswa kwe-18% ku-DR Lapho kuhlolwa i-lymph node metastasis (50% kanye ne-32%, ngokulandelana). Kodwa-ke, akukho okutholakele okwakubalulekile ngokwezibalo, kusho ababhali bocwaningo.
Abacwaningi bakholelwa ukuthi ukuzwela okuphezulu nokucacile kungase kunikeze i-PSMA PET / CT inzuzo ku-PCa staging kanye nokubona izilonda ezincane, kodwa futhi bavume ukuthi ukutholakala kwendlela kuyinkinga. I-MRI yamapharamitha amaningi ingase ibe usizo ekuhloleni ukuphindaphinda kwendawo kanye ne-PCa ebalulekile emtholampilo, kodwa abalobi bocwaningo bayavuma ukuthi i-interrobserver heterogeneity ingase ibe yinkinga nge-mpMRI.
Kodwa-ke, imiphumela yonke yokuhlaziywa kwe-meta iphakamisa ukuthi zombili izindlela zinendima ekuxilongeni i-PCa BCR, futhi zikhomba izifundo ezizokwenzeka esikhathini esizayo ezinganikeza ukucaca okukhulu kulokhu.
U-Xu kanye nozakwabo bagcizelele umthelela omkhulu wemiphumela yocwaningo ekusebenzeni komtholampilo. Babonisa ukuthi amandla okuxilonga afanayo we-PSMA PET / CT kanye ne-mpMRI abonisa ukuphumelela kwazo zombili izindlela ekutholeni i-BCR kuziguli ze-PCa. Kodwa-ke, bagcizelele isidingo socwaningo olwengeziwe ukuze kuhlolwe ukufinyeleleka, ukufinyeleleka, kanye nempumelelo yezindleko zalezi zindlela zokuthwebula izithombe.
Lapho bexoxa ngemikhawulo yocwaningo, ababhali bavuma ukuthi usayizi omncane wesampula weziguli ezingama-290 wawuwumphumela wokugxila kwabo ekuhlaziyeni izifundo zokuqhathanisa zokuthola i-BCR ngaphakathi kwamaqembu esiguli afanayo. Baphinde baphakamisa ukuthi kungenzeka kube nokuchema emiphumeleni ngenxa yezinqubo ezahlukene zokucabanga nezici zesiguli kuzo zonke izifundo eziyisithupha abazibuyekezile.
————————————————————————————————————————————————— ——————————————————————————————————————————
Ngokuthuthuka kobuchwepheshe bezithombe zezokwelapha, kuphuma izinkampani eziningi ezingahlinzeka ngemikhiqizo yokuthwebula izithombe, njengama-injection namasirinji.I-LnkMedubuchwepheshe bezokwelapha bungenye yazo. Sihlinzeka ngephothifoliyo egcwele yemikhiqizo yokuhlola eyisiza:I-CT injector eyodwa,I-CT double head injector,Umjovo we-MRIfuthiI-DSA high pressure injector. Basebenza kahle ngemikhiqizo ehlukahlukene yesithwebuli se-CT/MRI njenge-GE, Philips, Siemens. Ngaphandle komjovo, siphinde sinikeze isirinji kanye neshubhu esetshenziswayo yezinhlobo ezahlukene zomjovo ohlanganisa i-Medrad/Bayer, iMallincrodt/Guerbet, iNemoto, iMedtron, i-Ulrich.
Okulandelayo amandla ethu ayisisekelo: izikhathi zokulethwa okusheshayo; Qedela iziqu zesitifiketi, iminyaka eminingi yesipiliyoni sokuthekelisa, inqubo yokuhlola ikhwalithi ephelele, imikhiqizo esebenza ngokugcwele, siyawamukela ngemfudumalo umbuzo wakho.
Isikhathi sokuthumela: Apr-18-2024
